3 days ago
Podcast: AAIC 2025 highlights and the latest trends in Alzheimer's disease IVDs
This year's Alzheimer's Association International Conference (AAIC), which took place in Toronto, Canada, on 27-31 July, featured a range of data readouts from companies developing in vitro diagnostics (IVD) for the early diagnosis of Alzheimer's disease.
A key theme among many presentations was the use of ALZpath's pTau217 antibody.
The biomarker featured in seven presentations and 30 posters. A presentation from Roche shared new real-world data confirming that its blood-based biomarker, Elecsys pTau217, provided comparable results to PET scan and cerebrospinal fluid (CSF) diagnostics for rule-in and rule-out diagnosis of amyloid pathology.
Medical Device Network sat down with Selena Yu, senior medical analyst at GlobalData, to learn more about the key IVD news from this year's AAIC and the direction in which Alzheimer's disease research and development is currently headed.
You can listen to the podcast below:
Este contenido insertado no está disponible en tu región.
"Podcast: AAIC 2025 highlights and the latest trends in Alzheimer's disease IVDs" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Error al recuperar los datos
Inicia sesión para acceder a tu cartera de valores
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
